Saturday, February 7, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Earnings

Nel ASA Shares Face Pressure as Hydrogen Specialist Reports Steep Order Decline

Robert Sasse by Robert Sasse
October 29, 2025
in Earnings, European Markets, Hydrogen
0
Nel ASA Stock
0
SHARES
10
VIEWS
Share on FacebookShare on Twitter

Norwegian hydrogen technology company Nel ASA finds itself navigating turbulent waters following the release of its third-quarter 2025 results. The company’s financial performance reveals a concerning contraction in order activity, casting a shadow over its near-term growth trajectory despite some operational improvements.

Financial Performance Highlights

Nel’s revenue for the third quarter of 2025 declined significantly, falling 17 percent to 303 million Norwegian kroner. While the top-line figure showed weakness, the company demonstrated progress on operational efficiency metrics. The EBITDA loss narrowed substantially to 37 million kroner, a marked improvement from the 90 million kroner loss recorded in the same period last year. Similarly, the net loss contracted from 115 million kroner to 85 million kroner.

The company maintains a solid liquidity position with 1.757 billion kroner in cash reserves, providing a financial buffer during this challenging market phase.

Order Book Concerns Deepen

The most alarming aspect of Nel’s quarterly report comes from its order activity. New order intake plummeted by 64 percent to just 57 million kroner, while the total order backlog shrank by 47 percent year-over-year to 984 million kroner. Even compared to the previous quarter, the order situation deteriorated by 21 percent.

This decline in orders presents a puzzling contrast to the company’s continued involvement in over 500 megawatts of FEED studies. The critical question facing management is why these preliminary studies are failing to convert into firm contracts.

Should investors sell immediately? Or is it worth buying Nel ASA?

Diverging Segment Performance

An examination of Nel’s business segments reveals a mixed operational picture:

  • PEM Electrolyzers: Revenue declined 15 percent, though the segment’s EBITDA loss improved to 34 million kroner from 57 million kroner in the prior year period
  • Alkaline Electrolyzers: Revenue decreased 17 percent, but the segment achieved positive EBITDA of 26 million kroner, indicating operational enhancements

Strategic Partnerships and Future Outlook

Nel’s strategic alliances with industry giants General Motors, Reliance, and Samsung E&A remain intact, providing some stability amid the current challenges. However, the broader hydrogen sector continues to face headwinds including project delays and tempered demand, with Nel squarely positioned within this difficult environment.

The company’s recovery hopes appear pinned on its next-generation technology platform. CEO Håkon Volldal emphasized the dual focus on commercializing new technologies while preserving cash. The planned launch of the pressurized alkaline platform in the first half of 2026 promises substantially reduced capital investment requirements and improved energy efficiency.

Whether this forthcoming PEM solution can deliver the necessary performance improvements to revitalize order growth remains the decisive factor for the hydrogen pioneer’s future trajectory.

Ad

Nel ASA Stock: Buy or Sell?! New Nel ASA Analysis from February 7 delivers the answer:

The latest Nel ASA figures speak for themselves: Urgent action needed for Nel ASA investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from February 7.

Nel ASA: Buy or sell? Read more here...

Tags: Nel ASA
Robert Sasse

Robert Sasse

About Dr. Robert Sasse Accomplished economist, entrepreneur, and profound expert in financial markets. Dr. Robert Sasse holds a doctorate in economics and combines academic rigor with practical entrepreneurial experience. His deep expertise in economic relationships and unwavering conviction for a free-market liberal economic order drives his mission to provide investors with well-founded knowledge and guidance.
Areas of Expertise:
  • Economic Theory and Practice
  • Free-Market Economics
  • Entrepreneurship and Business Strategy
  • Investment Philosophy
Dr. Sasse's unique combination of academic knowledge and real-world business experience enables him to provide investors with comprehensive insights that bridge theory and practice.

Related Posts

ServiceNow Stock
AI & Quantum Computing

ServiceNow Shares Face Market Skepticism Despite Record Performance

February 7, 2026
Orthofix Medical Stock
Earnings

Orthofix Medical Strengthens Scientific Foundation for Biologics Portfolio

February 7, 2026
Myers Industries Stock
Analysis

Myers Industries Set to Report Full-Year and Q4 2025 Results

February 7, 2026
Next Post
Asml Stock

ASML Shares Surge on Strong Earnings and AI Integration Strategy

Metaplanet Stock

Japanese Firm Metaplanet Pioneers Bitcoin-Backed Share Buyback

CureVac Stock

CureVac Shareholders Face Critical Deadline in BioNTech Takeover Bid

Recommended

Technology Artificial intelligence Market Capitalization

Analyst Reaffirms Positive Outlook on Airgain with Price Target Increase Chief Revenue Officer Resigns

2 years ago
COST stock news

Apples Official Obsolescence of the 2012 MacBook Pro 13inch Model

2 years ago
Hain Celestial Stock

Hain Celestial Faces Critical Test with Upcoming Earnings Release

6 months ago
Piper Jaffray Stock

Mixed Signals Emerge from Piper Sandler’s Strong Quarterly Performance

6 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

A New Chapter for First Busey as CrossFirst Merger Finalizes

Golden Entertainment to Exit Public Markets in Strategic Privatization Deal

Myers Industries Set to Report Full-Year and Q4 2025 Results

OneSpan Strengthens Mobile Security Arsenal with Strategic Acquisition

Riley Exploration Permian Bolsters Board with Industry Veteran Amid Shareholder Activity

Great Lakes Dredge & Dock: A Cash Flow Inflection Point Approaches

Trending

Yirendai Stock
AI & Quantum Computing

Yirendai Charts a New Course with Tech-Driven Strategy

by Kennethcix
February 7, 2026
0

The Chinese fintech firm Yirendai is actively pursuing a strategic pivot, embedding advanced technologies like blockchain and...

ServiceNow Stock

ServiceNow Shares Face Market Skepticism Despite Record Performance

February 7, 2026
Orthofix Medical Stock

Orthofix Medical Strengthens Scientific Foundation for Biologics Portfolio

February 7, 2026
CrossFirst Bankshares Stock

A New Chapter for First Busey as CrossFirst Merger Finalizes

February 7, 2026
Golden Entertainment Stock

Golden Entertainment to Exit Public Markets in Strategic Privatization Deal

February 7, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Yirendai Charts a New Course with Tech-Driven Strategy
  • ServiceNow Shares Face Market Skepticism Despite Record Performance
  • Orthofix Medical Strengthens Scientific Foundation for Biologics Portfolio

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com